Abstract 2852: Obinutuzumab (GA101) efficacy in chronic lymphocytic leukemia in vitro is not diminished in high risk patients. - Archive ouverte HAL
Communication Dans Un Congrès Année : 2013

Abstract 2852: Obinutuzumab (GA101) efficacy in chronic lymphocytic leukemia in vitro is not diminished in high risk patients.

Domaines

Cancer Immunologie

Anne QUILLET-MARY  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-02348799

Soumis le : mardi 5 novembre 2019-14:29:41

Dernière modification le : jeudi 14 novembre 2024-14:44:02

Fichier non déposé

Dates et versions

hal-02348799 , version 1 (05-11-2019)

Identifiants

Citer

Loic Ysebaert, Emilie Laprevotte, Christian Klein, Jean-Jacques Fournié, Anne Quillet-Mary. Abstract 2852: Obinutuzumab (GA101) efficacy in chronic lymphocytic leukemia in vitro is not diminished in high risk patients.. Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC, Apr 2013, Washington, United States. pp.2852-2852, ⟨10.1158/1538-7445.AM2013-2852⟩. ⟨hal-02348799⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BOURGOGNE CNRS IMB_UMR5584 FNCLCC VALDAURELLE BS UNIV-MONTPELLIER IRCM UNIV-UT3 UT3-TOULOUSEINP
48 Consultations
0 Téléchargements

Altmetric

Partager

More